United Therapeutics Corporation
1110 Spring Street
Silver Spring
Maryland
20910
United States
Tel: 301-608-9292
Fax: 301-608-9291
Website: http://www.unither.com/
395 articles about United Therapeutics Corporation
-
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference
4/16/2024
United Therapeutics Corporation today announced that recent research across its commercial and development portfolio will be presented at the American Thoracic Society (ATS) International Conference in San Diego on May 17-22, 2024.
-
United Therapeutics Announces the First Comprehensive Review Publication on Xenotransplantation
3/26/2024
United Therapeutics Corporation, a public benefit corporation, announced the online availability of a review manuscript titled “Physiological Basis for Xenotransplantation from Genetically-Modified Pigs to Humans: A Review,” in the journal Physiological Reviews.
-
United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program
3/25/2024
United Therapeutics Corporation, a public benefit corporation, announced that its Board of Directors has authorized the company to purchase up to $1 billion of United Therapeutics’ common stock.
-
United Therapeutics Corporation to Present at the Leerink Partners Global Biopharma Conference 2024
3/5/2024
United Therapeutics Corporation, a public benefit corporation, announced that Patrick Poisson, Executive Vice President, Technical Operations, will provide an overview and update on the company’s operations during a fireside chat session at the Leerink Partners Global Biopharma Conference 2024 in Miami Beach, Florida.
-
United Therapeutics Corporation to Present at the TD Cowen 44th Annual Health Care Conference
2/27/2024
United Therapeutics Corporation, a public benefit corporation, announced that Michael Benkowitz, President and Chief Operating Officer, will provide an overview and update on the company’s operations during a fireside chat session at the TD Cowen 44th Annual Health Care Conference in Boston.
-
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2023 Financial Results
2/21/2024
United Therapeutics Corporation, a public benefit corporation, announced its financial results for the quarter and year ended December 31, 2023.
-
The litigation alleges the regulator allowed its competitor Liquidia to skirt FDA precedents by amending an already pending NDA to add a PH-ILD indication instead of filing a new application.
-
United Therapeutics Corporation to Report Fourth Quarter and Full Year 2023 Financial Results Before the Market Opens on Wednesday, February 21, 2024
2/14/2024
United Therapeutics Corporation, announced that it will report its fourth quarter and full year 2023 financial results before the market opens on Wednesday, February 21, 2024.
-
United Therapeutics Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference
12/29/2023
United Therapeutics Corporation, a public benefit corporation, announced that Dr. Martine Rothblatt, Chairperson and Chief Executive Officer, will provide an overview and update on the company’s business during a presentation at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco.
-
United Therapeutics and Miromatrix Medical Announce Completion of Tender Offer and Merger
12/13/2023
United Therapeutics and Miromatrix Medical Announce Completion of Tender Offer and Merger.
-
United Therapeutics and Miromatrix Medical Announce Successful Tender Offer
12/12/2023
United Therapeutics Corporation and Miromatrix Medical Inc. announced the results of the previously announced tender offer by Morpheus Subsidiary Inc., a wholly owned subsidiary of United Therapeutics, to acquire all outstanding shares of Miromatrix.
-
United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2024
12/7/2023
United Therapeutics, a public benefit corporation, announced that the company has been named on Newsweek’s list of America’s Most Responsible Companies 2024.
-
United Therapeutics Corporation Reports Third Quarter 2023 Financial Results
11/1/2023
United Therapeutics Corporation, a public benefit corporation, announced its financial results for the quarter ended September 30, 2023.
-
United Therapeutics Corporation to Present at the UBS Biopharma Conference 2023
10/31/2023
United Therapeutics Corporation announced that Patrick Poisson, Executive Vice President, Technical Operations, will provide an overview and update on the company’s business during a fireside chat session at the UBS Biopharma Conference 2023 in Miami Beach, Florida.
-
United Therapeutics Announces First Patient Enrolled in Phase 3 TETON PPF Study of Nebulized Tyvaso in Patients with Progressive Pulmonary Fibrosis
10/31/2023
United Therapeutics Corporation, a public benefit corporation, announced that the first patient has enrolled in the registration-phase TETON PPF study, which will evaluate nebulized Tyvaso® Inhalation Solution in 698 adult patients with progressive pulmonary fibrosis.
-
United Therapeutics to Acquire Miromatrix Medical
10/30/2023
United Therapeutics Corporation and Miromatrix Medical Inc. announced a definitive agreement for United Therapeutics to acquire Miromatrix.
-
United Therapeutics Corporation to Report Third Quarter 2023 Financial Results Before the Market Opens on Wednesday, November 1, 2023
10/25/2023
United Therapeutics Corporation (Nasdaq: UTHR ), announced today that it will report its third quarter 2023 financial results before the market opens on Wednesday, November 1, 2023.
-
United Therapeutics Issues its 2023 Corporate Responsibility and Public Benefit Report
9/12/2023
United Therapeutics Corporation, a public benefit corporation, announced the release of its 2023 Corporate Responsibility and Public Benefit Report covering its 2022 progress toward its public benefit goals and objectives and summarizing its efforts to advance the interests of its patients and other stakeholders.
-
United Therapeutics Corporation to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
9/1/2023
United Therapeutics Corporation announced that James Edgemond, Chief Financial Officer and Treasurer, will provide an overview and update on the company’s business during a fireside chat session at the Morgan Stanley 21st Annual Global Healthcare Conference in New York City.
-
United Therapeutics Corporation Reports Second Quarter 2023 Financial Results
8/2/2023
United Therapeutics Corporation, a public benefit corporation, announced its financial results for the quarter ended June 30, 2023.